Literature DB >> 10207416

Renal artery stenosis: evaluation with conventional angiography versus gadolinium-enhanced MR angiography.

M Gilfeather1, H C Yoon, E S Siegelman, L Axel, A H Stolpen, R D Shlansky-Goldberg, R A Baum, M C Soulen, M D Schnall.   

Abstract

PURPOSE: To evaluate the interobserver and intermodality variability of conventional angiography and gadolinium-enhanced magnetic resonance (MR) angiography in the assessment of renal artery stenosis.
MATERIALS AND METHODS: Fifty-four patients underwent conventional angiography and gadolinium-enhanced three-dimensional gradient-echo MR angiography. Three angiographers blinded to each other's interpretations and the MR angiographic findings assessed the conventional angiograms for renal artery stenosis. Similarly, three blinded MR imagers evaluated the MR angiograms.
RESULTS: Interobserver variability for the degree of renal artery stenosis in the 107 kidneys evaluated was not significantly different between the two modalities. The mean SD of the degree of stenosis was 6.9% at MR angiography versus 7.5% at conventional angiography (alpha < or = .05, P > .05). In 70 kidneys (65%), the average degree of stenosis reported by the readers for the two modalities differed by 10% or less. In 22 cases (21%), the degree of stenosis was overestimated with MR angiography by more than 10% relative to the results of conventional angiography. In 15 cases (14%), the degree of stenosis was underestimated with MR angiography by more than 10%.
CONCLUSION: Gadolinium-enhanced MR angiography permits evaluation of renal artery stenosis with an interobserver variability comparable with that of conventional angiography.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10207416     DOI: 10.1148/radiology.210.2.r99fe44367

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  8 in total

Review 1.  Current concepts in the evaluation of vascular disease: magnetic resonance and computed tomographic angiography.

Authors:  B D Toombs; J M Jing
Journal:  Tex Heart Inst J       Date:  2000

Review 2.  Contrast medium administration and image acquisition parameters in renal CT angiography: what radiologists need to know.

Authors:  Charbel Saade; Ibrahim Alsheikh Deeb; Maha Mohamad; Hussain Al-Mohiy; Fadi El-Merhi
Journal:  Diagn Interv Radiol       Date:  2016 Mar-Apr       Impact factor: 2.630

3.  Renal artery stenosis: comparative evaluation of gadolinium-enhanced MRA and DSA.

Authors:  F Stacul; S Gava; M Belgrano; S Cernic; L Pagnan; F Pozzi Mucelli; M A Cova
Journal:  Radiol Med       Date:  2008-05-15       Impact factor: 3.469

4.  Pulmonary oedema, think beyond the heart even in the presence of severe left ventricular systolic dysfunction.

Authors:  Shohreh Honarbakhsh; Mohammad Chowdhury; Andrew Deaner; Fahad Farooqi
Journal:  BMJ Case Rep       Date:  2015-11-03

5.  Atherosclerotic ischemic renal disease. Diagnosis and prevalence in an hypertensive and/or uremic elderly population.

Authors:  Giorgio Coen; Santo Calabria; Silvia Lai; Eleonora Moscaritolo; Italo Nofroni; Giuseppe Ronga; Michele Rossi; Guido Ventroni; Daniela Sardella; Michele Ferrannini; Alvaro Zaccaria; Rosario Cianci
Journal:  BMC Nephrol       Date:  2003-02-06       Impact factor: 2.388

6.  An augmented patient-specific approach to administration of contrast agent for CT renal angiography.

Authors:  Charbel Saade; Nadine Hamieh; Ibrahim Al-Sheikh Deeb; Maurice Haddad; Alain S Abi-Ghanem; Diamond Ghieh; Fadi El-Merhi
Journal:  Int Braz J Urol       Date:  2019 Sep-Oct       Impact factor: 1.541

7.  Cortical and medullary oxygenation evaluation of kidneys with renal artery stenosis by BOLD-MRI.

Authors:  Long Zhao; Guoqi Li; Fanyu Meng; Zhonghua Sun; Jiayi Liu
Journal:  PLoS One       Date:  2022-03-10       Impact factor: 3.240

8.  Ultrasound diagnostics of renal artery stenosis: Stenosis criteria, CEUS and recurrent in-stent stenosis.

Authors:  W Schäberle; L Leyerer; W Schierling; K Pfister
Journal:  Gefasschirurgie       Date:  2015-08-28
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.